Paper7366733
Role of NK cells in tumour growth and metastasis in beige mice.
Talmadge JE and 3 others. Nature, 1980. Cited by 516 papers, by iCite.
Cite this record
ConductScience Library. Role of NK cells in tumour growth and metastasis in beige mice. Papers, record 7366733. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7366733
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunity, Cellular | Major topic |
| Immunity, Innate | Major topic |
| Killer Cells, Natural | Major topic |
| Melanoma | Major topic |
| Mice, Mutant Strains | Major topic |
| Animals | |
| Lung Neoplasms | |
| Mice | |
| Models, Biological | |
| Neoplasm Metastasis | |
| Neoplasms, Experimental |
Source PubMed
Cited by133
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 516 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41107895 | The role of NK cells in regulating tumorimmunity: current state, challenges and future strategies. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/41107895 | PubMed |
| 38022613 | Modulation of natural killer cell exhaustion in the lungs: the key components from lung microenvironment and lung tumor microenvironment. | Front Immunol | 2023 | https://conductscience.org/library/papers/38022613 | PubMed |
| 37762486 | Therapeutic Anti-KIR Antibody of 1-7F9 Attenuates the Antitumor Effects of Expanded and Activated Human Primary Natural Killer Cells on In Vitro Glioblastoma-like Cells and Orthotopic Tumors Derived Therefrom. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37762486 | PubMed |
| 36844875 | The Efficacy and Hemorheological Indexes of Ginseng and Its Active Components for Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. | J Oncol | 2023 | https://conductscience.org/library/papers/36844875 | PubMed |
| 35326467 | Aging of the Immune System: Focus on Natural Killer Cells Phenotype and Functions. | Cells | 2022 | https://conductscience.org/library/papers/35326467 | PubMed |
| 35325068 | Immunotherapeutic targeting of activating natural killer cell receptors and their ligands in cancer. | Clin Exp Immunol | 2022 | https://conductscience.org/library/papers/35325068 | PubMed |
| 35110548 | Primary tumor associated macrophages activate programs of invasion and dormancy in disseminating tumor cells. | Nat Commun | 2022 | https://conductscience.org/library/papers/35110548 | PubMed |
| 35001010 | Immunoenhancing Effects of Euglena gracilis on a Cyclophosphamide-Induced Immunosuppressive Mouse Model. | J Microbiol Biotechnol | 2022 | https://conductscience.org/library/papers/35001010 | PubMed |
| 34788549 | Innate Immunity and Cancer Pathophysiology. | Annu Rev Pathol | 2022 | https://conductscience.org/library/papers/34788549 | PubMed |
| 34745769 | Metformin promotes anticancer activity of NK cells in a p38 MAPK dependent manner. | Oncoimmunology | 2021 | https://conductscience.org/library/papers/34745769 | PubMed |
| 34576141 | Ex Vivo Expanded and Activated Natural Killer Cells Prolong the Overall Survival of Mice with Glioblastoma-like Cell-Derived Tumors. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34576141 | PubMed |
| 34014424 | Myeloid derived suppressor cells and the release of micro-metastases from dormancy. | Clin Exp Metastasis | 2021 | https://conductscience.org/library/papers/34014424 | PubMed |
| 33546248 | Killing the Invaders: NK Cell Impact in Tumors and Anti-Tumor Therapy. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33546248 | PubMed |
| 31662515 | Impact of Awake Breast Cancer Surgery on Postoperative Lymphocyte Responses. | In Vivo | 2019 | https://conductscience.org/library/papers/31662515 | PubMed |
| 31172847 | Redirected optimized cell killing (ROCK®): A highly versatile multispecific fit-for-purpose antibody platform for engaging innate immunity. | MAbs | 2019 | https://conductscience.org/library/papers/31172847 | PubMed |
| 30546365 | Ginsenoside F1 Promotes Cytotoxic Activity of NK Cells via Insulin-Like Growth Factor-1-Dependent Mechanism. | Front Immunol | 2018 | https://conductscience.org/library/papers/30546365 | PubMed |
| 29867983 | IL-15 Overcomes Hepatocellular Carcinoma-Induced NK Cell Dysfunction. | Front Immunol | 2018 | https://conductscience.org/library/papers/29867983 | PubMed |
| 29456538 | An Uncoupling of Canonical Phenotypic Markers and Functional Potency of Ex Vivo-Expanded Natural Killer Cells. | Front Immunol | 2018 | https://conductscience.org/library/papers/29456538 | PubMed |
| 29354116 | Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review. | Front Immunol | 2017 | https://conductscience.org/library/papers/29354116 | PubMed |
| 29031720 | Brown adipocytes can display a mammary basal myoepithelial cell phenotype in vivo. | Mol Metab | 2017 | https://conductscience.org/library/papers/29031720 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7366733
GET https://conductscience.org/api/papers/v1/7366733/cited_by?page=2